Table 1 Patients tumor characteristic
Min–max | Median | Mean ± sd/n (%) | ||
|---|---|---|---|---|
Age | 36.0–85.0 | 63.0 | 62.5 ± 8.8 | |
Sex | Female | 12 (6.7%) | ||
Male | 166 (93.3%) | |||
Following time (months) | 1.0–36.0 | 7.0 | 8.3 ± 7.3 | |
Metastasis | ||||
Brain | 24 (13.5%) | |||
Bone | 133 (74.7%) | |||
Liver | 84 (47.2%) | |||
Opp. lung | 11 (6.2%) | |||
Pleura | 25 (14.0%) | |||
Adrenal | 52 (29.2%) | |||
Pancreas | 16 (9.0%) | |||
Bone + brain | 5 (2.8%) | |||
Bone + liver | 31 (17.4%) | |||
Single metastasis | 57 (32.0%) | |||
Dual metastasis | 73 (41.0%) | |||
Three or more metastasis | 46 (25.8%) | |||
Tumor diameter (cm) | 0–3 | 18 (10.1%) | ||
3–7 | 90 (50.6%) | |||
> 7 | 70 (39.3%) | |||
Tumor N stage | I | 6 (3.4%) | ||
II | 60 (33.7%) | |||
III | 112 (62.9%) | |||
Living deceased | 4 (2.2%) | |||
174 (97.8%) | ||||